Published in Gene Therapy Weekly, May 13th, 1996
Globo H is a breast cancer associated carbohydrate antigen which was initially defined by the murine monoclonal antibody MBr1. G. Ragupathi of the Memorial Sloan-Kettering Cancer Center noted at the 87th Annual Meeting of the American Association for Cancer Research, held April 20-24, 1996, in Washington, DC, that the protein for Globo H was very difficult to synthesize initially. But now that a process has been developed, it can readily be linked with conjugates to create an anticancer vaccine.
"This is a new antigen, people are not familiar with it yet,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.